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Background: Patients with heart failure (HF) and preserved ejection fraction (EF) form a heterogeneous group that includes a subset with 
previously low EF. We postulated that HF patients with “recovered” EF would be distinct from those with preserved or reduced EF.
Methods: We utilized the electronic medical record to identify 326 patients in our ambulatory referral practice with current or prior HF (defined 
by Framingham criteria or EF<40%) and serial EF’s spanning at least 9 mos. Hypertrophic and infiltrative disease were excluded. Using the lowest 
and the most recent EF’s, we sorted patients into EF always >/=40% (HFpEF), EF recovered to >/=40% (recovered EF) and EF<40% (low EF). We 
compared clinical, laboratory and echocardiographic features across the 3 groups with standard chi-square and ANOVA tests.
Results: Of 145 with EF>/=40%, 100 (69%) had recovered EF and 45 (31%) had HFpEF. Recovered EF patients were distinct from HFpEF in having 
larger ventricles, lower systolic blood pressures, better glomerular filtration rate, younger age, less atrial fibrillation and diabetes mellitus. Recovered 
EF patients were similar to the 181 patients with low EF (Table).
Conclusions: The majority of patients in referral clinic with HF and EF >/=40% have recovered EF. These subjects are clinically distinct from HFpEF 
patients and closely resemble those with low EF. The growing recovered EF population has potential implications for clinical trials and should be 
specifically targeted for further research. 
Table I: Demographic and clinical characteristics for each EF category
HFpEF Recovered EF Low EF P value
N=45 N=100 N=181
DEMOGRAPHICS
Mean age (years) 71±13 55±15 59±14 P<0.0001*
Male sex - % 40 52 76 P<0.0001+
Race - % P=0.86+
White 71 67 72
Black 16 16 16
Other 13 17 12
CLINICAL PROFILE
Mean systolic BP (mmgHg) 130±19 123±19 117±17 P<0.0001*
Mean diastolic BP (mmHg) 72±11 73±12 72±12 P=0.78*
Medical history - %
Atrial fibrillation 46.7 23.0 28.2 P=0.01+
Hypertension 73.3 44.0 48.6 P=0.0035+
Coronary artery disease 42.2 28.0 43.1 P=0.04+
Diabetes mellitus 42.2 21.0 29.3 P=0.03+
LABORATORY
Estimated GFR, mean (mL/min/1.73m2) 50±20.5 75± 30.1 68±34.1 P=0.0005*
LV ejection fraction, mean (%) 56.0%±8.2 % 48.3%±6.5% 24.6%± 6.9% P<0.0001*
LV end diastolic dimension, mean (cm) 4.6±0.7 5.2±0.7 6.4±0.9 P<0.0001*
LV posterior wall thickness, mean (mm) 11±2 10±3 10±2 P=0.0016*
*p value from one way ANOVA   +p value from chi squared test
